ARF6 INHIBITOR FOR TREATMENT OF ACUTE LUNG INJURY/ACUTE RESPIRATORY DISTRESS SYNDROME

$3,266,291FY2020Defense Health AgencyDOD

Navigen Inc

Investigators

View source on USAspending →